Home › Asset managers › Compare 2024-2025 › State Street vs DWS
State Street 2024-2025 · DWS 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 73,594 | 68,104 | 5,298 | 192 | 92.8% | 92.6% |
| Board proposals | 57,454 | 52,841 | 4,438 | 175 | 92.3% | 92.1% |
| E&S shareholder proposals | 254 | 153 | 100 | 1 | 60.5% | 60.3% |
| Other items | 15,886 | 15,110 | 760 | 16 | 95.2% | 95.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
4,438 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | State Street | DWS |
|---|---|---|---|---|---|---|
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Undertakings to be Made by the Relevant Entities in Respect of the Measures on the Dilution of the Company's Current Return by the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | AGAINST 9 funds |
FOR 2 funds |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Validity Period of the Resolution Prior to the Issuance Capital Structure |
Board | For | AGAINST 9 funds |
FOR 2 funds |
| COSMO AM&T CO. LTD. | March 24, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| COSMO AM&T CO. LTD. | March 24, 2025 | Elect Hong Dong-hwan as Inside Director Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| COSMOS PHARMACEUTICAL CORP. | August 20, 2024 | Elect Director Yokoyama, Hideaki Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| COSTAMARE INC. | October 3, 2024 | Elect Director Gregory Zikos Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| COSTAMARE INC. | October 3, 2024 | Elect Director Vagn Lehd Moller Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| COSTAR GROUP INC. | June 26, 2025 | Proposal to approve, on an advisory basis, the Company's executive compensation. Other Social Issues |
Board | For | FOR 28 funds |
AGAINST 11 funds |
| COTY INC. | November 7, 2024 | Election of Directors: Beatrice Ballini Director Elections |
Board | For | WITHHOLD 10 funds |
FOR 4 funds |
| COTY INC. | November 7, 2024 | Election of Directors: Gordon von Bretten Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 4 funds |
| COTY INC. | November 7, 2024 | Election of Directors: Joachim Creus Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 4 funds |
| COTY INC. | November 7, 2024 | Election of Directors: Lubomira Rochet Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 4 funds |
| COTY INC. | November 7, 2024 | Election of Directors: Peter Harf Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 4 funds |
| COTY INC. | November 7, 2024 | Election of Directors: Sue Y. Nabi Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 4 funds |
| COUPANG INC. | June 12, 2025 | Election of Directors: Neil Mehta Director Elections |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| COURSERA INC. | May 20, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| COVENANT LOGISTICS GROUP INC. | May 14, 2025 | To consider and act upon a proposal to elect nine (9) directors: Bradley A. Moline Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| COVENANT LOGISTICS GROUP INC. | May 14, 2025 | To consider and act upon a proposal to elect nine (9) directors: Joey B. Hogan Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| COVENANT LOGISTICS GROUP INC. | May 14, 2025 | To consider and act upon a proposal to elect nine (9) directors: Rachel Parker-Hatchett Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| CPI EUROPE AG | May 20, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CRE LOGISTICS REIT INC. | September 30, 2024 | Elect Executive Director Ito, Tsuyoshi Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| CREDIT AGRICOLE SA | May 14, 2025 | Approve Remuneration Policy of Jerome Grivet, Vice-CEO Compensation |
Board | For | FOR 10 funds |
AGAINST 9 funds |
| CREDITACCESS GRAMEEN LTD. | August 12, 2024 | Amend CAGL Employees Stock Option Plan-2011 Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| CREDITACCESS GRAMEEN LTD. | August 12, 2024 | Approve Increase in Borrowing Limits Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| CREDITO EMILIANO SPA | April 30, 2025 | Approve Remuneration Policy Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| CREDITO EMILIANO SPA | April 30, 2025 | Approve Second Section of the Remuneration Report Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| CREDITO EMILIANO SPA | April 30, 2025 | Approve Severance Payments Policy Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| CRH PLC | May 8, 2025 | By separate resolutions, to re-elect the following Directors: Richie Boucher Director Elections |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| CRH PLC | May 8, 2025 | Disapplication of Pre-emption Rights Capital Structure |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| CRICUT INC. | May 28, 2025 | Election of Directors: Ashish Arora Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Billie Williamson Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Melissa Reiff Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| CRICUT INC. | May 28, 2025 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| CRINETICS PHARMACEUTICALS INC. | June 11, 2025 | To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: Matthew K. Fust Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| CROCS INC. | June 10, 2025 | Election of Directors: Ian M. Bickley Director Elections |
Board | For | WITHHOLD 10 funds |
FOR 1 fund |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Arrangement of Guarantees Capital Structure |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Arrangement of Guarantees Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Issuance of Debt Financing Instruments Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Issuance of Debt Financing Instruments Capital Structure |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CSSC SCIENCE & TECHNOLOGY CO. LTD. | January 13, 2025 | Approve Amount of Loan Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CSSC SCIENCE & TECHNOLOGY CO. LTD. | January 13, 2025 | Approve Provision of External Guarantees Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CSW INDUST | August 15, 2024 | Election of Directors: Michael Gambrell Director Elections |
Board | Not determined | WITHHOLD 4 funds |
FOR 1 fund |
| CSX CORP. | May 7, 2025 | Election of Directors: John J. Zillmer Director Elections |
Board | For | FOR 25 funds |
AGAINST 11 funds |
| CTP N.V. | April 22, 2025 | AUTHORIZE BOARD TO EXCLUDE PREEMPTIVE RIGHTS FROM SHARE ISSUANCES Capital Structure |
Board | For | FOR 1 fund |
AGAINST 4 funds |
| CTP N.V. | April 22, 2025 | GRANT BOARD AUTHORITY TO ISSUE SHARES UP TO 10 PERCENT OF ISSUED CAPITAL FOR GENERAL PURPOSES AND ADDITIONAL 10 PERCENT OF ISSUED CAPITAL IN CASE OF MERGERS, ACQUISITIONS, OR STRATEGIC ALLIANCES Capital Structure |
Board | For | FOR 1 fund |
AGAINST 4 funds |
| CTS EVENTIM AG & CO. KGAA | May 21, 2025 | Elect Cornelius Baur to the Supervisory Board Director Elections |
Board | For | AGAINST 9 funds |
FOR 7 funds |
| CURBLINE PROPERTIES CORP. | May 7, 2025 | Election of two Class I Directors: Linda B. Abraham Director Elections |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| CUREVAC NV | June 24, 2025 | Reelect Klaus Schollmeier to Supervisory Board Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| CURTISS-WRIGHT CORP. | May 8, 2025 | Election of Directors: Robert J. Rivet Director Elections |
Board | For | WITHHOLD 11 funds |
FOR 5 funds |
| CUTERA INC. | July 15, 2024 | Election of Directors: Kevin Cameron Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Approve Remuneration Report Compensation |
Board | For | AGAINST 7 funds |
FOR 6 funds |
| CVR ENERGY INC. | June 5, 2025 | To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CVR ENERGY INC. | June 5, 2025 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 2 funds |
| CVRX INC. | June 3, 2025 | Election of Class I Directors: Mitch Hill Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| CVS HEALTH CORP. | May 15, 2025 | Election of Directors: Leslie V. Norwalk Director Elections |
Board | For | FOR 26 funds |
AGAINST 9 funds |
| CVS HEALTH CORP. | May 15, 2025 | Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. Shareholder Rights and Defenses |
Board | For | FOR 35 funds |
AGAINST 10 funds |
| D'AMICO INTERNATIONAL SHIPPING SA | April 29, 2025 | Approve DIS 2025-2027 Medium-Long Term Variable Incentive Plan Compensation |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| D'AMICO INTERNATIONAL SHIPPING SA | April 29, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends Capital Structure |
Board | For | FOR 8 funds |
AGAINST 6 funds |
| D'IETEREN GROUP | June 5, 2025 | Reelect HECHO SRL, Represented by Hugo De Stoop, as Independent Director Director Elections |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| DAH SING BANKING GROUP LTD. | May 30, 2025 | Elect Gary Pak-Ling Wang as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DAIDO STEEL CO. LTD. | June 25, 2025 | Elect Director Shimizu, Tetsuya Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| DAIDO STEEL CO. LTD. | June 25, 2025 | Elect Director and Audit Committee Member Niwa, Tetsuya Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| DAILY JOURNAL CORP. | February 19, 2025 | Election of four Directors: John B. Frank Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DAILY JOURNAL CORP. | February 19, 2025 | Election of four Directors: Steven Myhill-Jones Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DAITO TRUST CONSTRUCTION CO. LTD. | June 26, 2025 | Elect Director and Audit Committee Member Kawai, Shuji Director Elections |
Board | For | AGAINST 7 funds |
FOR 5 funds |
← Previous Page 11 of 45 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.